1.The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID–19)—China,2020http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4–41e9–9a9b-fea8db1a8f51]
2.Wang C, Horby PW, Hayden FG, Gao GF: A novel coronavirus outbreak of global health concern. Lancet 2020; 395(10223):470–473.
3.He X, Zhang L, Ran Q, Xiong A, Wang J, Wu D, Chen F, Li G: Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV. 2020;DOI: 10.1101/2020.02.03.20020206.
4. Oudit GY, Imai Y, Kuba K, Scholey JW, Penninger JM: The role of ACE2 in pulmonary diseases—relevance for the nephrologist. Nephrol Dial Transplant 2009; 24(5):1362–1365.
5.Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus A, Timens W, Turner AJ, Navis G, van Goor H: The emerging role of ACE2 in physiology and disease. The Journal of Pathology 2007; 212(1):1–11.
6.Khwaja A: KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120(4):c179–184.
7.Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z et al: Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203(2):622–630.
8.Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW et al: Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 2005; 67(2):698–705.
9.Lambeir AM, Durinx C, Scharpe S, De Meester I: Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003; 40(3):209–294.
10.Cha RH, Joh JS, Jeong I, Lee JY, Shin HS, Kim G, Kim Y, Critical Care Team of National Medical C: Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital. J Korean Med Sci 2015; 30(12):1807–1814.
11.Li W, Sui J, Huang IC, Kuhn JH, Radoshitzky SR, Marasco WA, Choe H, Farzan M: The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology 2007; 367(2):367–374.
12.Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G: Kidney impairment is associated with in-hospital death of COVID 19 patients 2020;DOI: 10.1101/2020.02.18.20023242.
13.Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y et al: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020.DOI: 10.1001/jama.2020.1585.
14.Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC et al: Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020.DOI: 10.1056/NEJMoa2002032.
15.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395(10223):497–506.
16.Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y et al: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020; 395(10223):507–513.
17.Li Z, Wu M, Guo J, Yao J, Liao X, Song S, Han M, Li J, Duan G, Zhou Y et al: Caution on Kidney Dysfunctions of 2019-nCoV Patients. 2020;DOI: 10.1101/2020.02.08.20021212.